KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Tax Provisions (2016 - 2025)

Gilead Sciences (GILD) has disclosed Tax Provisions for 17 consecutive years, with -$450.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions fell 216.88% year-over-year to -$450.0 million, compared with a TTM value of $941.0 million through Dec 2025, up 345.97%, and an annual FY2025 reading of $1.3 billion, up 509.48% over the prior year.
  • Tax Provisions was -$450.0 million for Q4 2025 at Gilead Sciences, down from $589.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $852.0 million in Q3 2021 and bottomed at -$450.0 million in Q4 2025.
  • Average Tax Provisions over 5 years is $286.2 million, with a median of $375.5 million recorded in 2021.
  • The sharpest move saw Tax Provisions crashed 303.42% in 2024, then skyrocketed 298.32% in 2025.
  • Year by year, Tax Provisions stood at $383.0 million in 2021, then rose by 3.92% to $398.0 million in 2022, then plummeted by 40.45% to $237.0 million in 2023, then surged by 62.45% to $385.0 million in 2024, then plummeted by 216.88% to -$450.0 million in 2025.
  • Business Quant data shows Tax Provisions for GILD at -$450.0 million in Q4 2025, $589.0 million in Q3 2025, and $468.0 million in Q2 2025.